Retrieve available abstracts of 20 articles: HTML format
Single Articles
July 2025
MIAO Y, Zhao K, Shang A Complexity of Prostate Cancer.
JAMA. 2025 Jul 9. doi: 10.1001/jama.2025.7196. PubMed
RAYCHAUDHURI R, Lin DW, Montgomery RB Complexity of Prostate Cancer-Reply.
JAMA. 2025 Jul 9. doi: 10.1001/jama.2025.7193. PubMed
March 2025
KINNAIRD A, Luger F, Cash H, Ghai S, et al Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis:
The OPTIMUM Randomized Clinical Trial.
JAMA. 2025 Mar 23:e253579. doi: 10.1001/jama.2025.3579. PubMedAbstract available
RAYCHAUDHURI R, Lin DW, Montgomery RB Prostate Cancer: A Review.
JAMA. 2025 Mar 10. doi: 10.1001/jama.2025.0228. PubMedAbstract available
November 2024
AJJAWI I, Loeb S, Cooperberg MR, Catalona WJ, et al Active Surveillance or Watchful Waiting for Intermediate-Risk Prostate Cancer,
2010-2020.
JAMA. 2024 Nov 20:e2420580. doi: 10.1001/jama.2024.20580. PubMed
August 2024
TURNER EL, Metcalfe C, Martin RM PSA Screening and Prostate Cancer Mortality-Reply.
JAMA. 2024 Aug 15. doi: 10.1001/jama.2024.13809. PubMed
GOLDSTEIN MR, Mascitelli L PSA Screening and Prostate Cancer Mortality.
JAMA. 2024 Aug 15. doi: 10.1001/jama.2024.13806. PubMed
D'AMICO AV PSA Screening and Prostate Cancer Mortality.
JAMA. 2024 Aug 15. doi: 10.1001/jama.2024.13803. PubMed
July 2024
NIK-AHD F, De Hoedt AM, Butler C, Anger JT, et al Prostate-Specific Antigen Values in Transgender Women Receiving Estrogen.
JAMA. 2024;332:335-337. PubMed
June 2024
FENG X, Zahed H, Onwuka J, Callister MEJ, et al Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials
of Cancer Screening: A Systematic Review and Meta-Analysis.
JAMA. 2024;331:1910-1917. PubMedAbstract available
May 2024
NEWCOMB LF, Schenk JM, Zheng Y, Liu M, et al Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for
Prostate Cancer.
JAMA. 2024 May 30. doi: 10.1001/jama.2024.6695. PubMedAbstract available
HARRIS E Urine-Based Test Could Help Identify Aggressive Prostate Cancer.
JAMA. 2024 May 17. doi: 10.1001/jama.2024.8424. PubMed
HARRIS E Prostate Cancer Cases Might Rise to 3 Million Globally by 2040.
JAMA. 2024 May 3. doi: 10.1001/jama.2024.6729. PubMed
April 2024
BAROCAS DA, Al Hussein Al Awamlh B, Koyama T Outcomes Following Localized Prostate Cancer Treatment-Reply.
JAMA. 2024 Apr 29. doi: 10.1001/jama.2024.5492. PubMed
HUANG TB, Ding XF Outcomes Following Localized Prostate Cancer Treatment.
JAMA. 2024 Apr 29. doi: 10.1001/jama.2024.5486. PubMed
CORNU JN Outcomes Following Localized Prostate Cancer Treatment.
JAMA. 2024 Apr 29. doi: 10.1001/jama.2024.5489. PubMed
AUVINEN A, Tammela TLJ, Mirtti T, Lilja H, et al Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen
Randomized Trial.
JAMA. 2024 Apr 6:e243841. doi: 10.1001/jama.2024.3841. PubMedAbstract available
TOSOIAN JJ, Penson DF, Chinnaiyan AM A Pragmatic Approach to Prostate Cancer Screening.
JAMA. 2024 Apr 6. doi: 10.1001/jama.2024.4089. PubMed
MARTIN RM, Turner EL, Young GJ, Metcalfe C, et al Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A
Secondary Analysis of the CAP Randomized Clinical Trial.
JAMA. 2024 Apr 6:e244011. doi: 10.1001/jama.2024.4011. PubMedAbstract available
January 2024
AL HUSSEIN AL AWAMLH B, Wallis CJD, Penson DF, Huang LC, et al Functional Outcomes After Localized Prostate Cancer Treatment.
JAMA. 2024;331:302-317. PubMedAbstract available